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Abstract
Objective:  to  determine  the  frequency,  complications  and  seasonality  at  which  respiratory  syn-
cytial  virus  (RSV)  infection  of  the  lower  respiratory  tract  causes  hospitalization  in  infants  of  age
1  year  or  less  in  6  cities  of  Colombia.
Methods: one-year  prospective  multicentric  observational  study  that  included  717  patients
presenting to  the  emergency  department  with  respiratory  symptoms  in  6  cities  of  Colombia.  Hos-
pitalized  children  were  tested  for  RSV  with  an  immunoﬂuorescence  rapid  test  in  nasopharyngeal
secretions.  Descriptive  and  statistical  analyses  of  the  population  were  conducted.
Results: the  study  population  included  717  patients  with  a  mean  age  of  3.6  months  (SD  3.25),
4:3 male:  female  ratio  and  a  positive  RSV  LRTI  prevalence  of  30.0%  (216  infants/City,  range
26.0  -  49.0%).  Risk  factors  for  RSV  LRTI  were  found  in  8.2%  of  the  population,  of  which  28.8%
were  RSV  positive.  RSV  positive  and  negative  groups  were  compared  using  a  two-tailed  t  test
with  95.0%CI,  p  <  0.05.  No  statistically  signiﬁcant  differences  were  found.  All  cities  presented
speciﬁc  year  trimesters  in  the  occurrence  of  RSV  LRTI.
Conclusions:  the  RSV  caused  1  in  3  LRTI  hospitalizations  in  the  population,  with  an  incidence  of
30.0%.  This  conﬁrms  a  continuous  circulation  of  RSV  in  Colombia  varying  by  geographic  location.
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respiratório;
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Internac¸ão
Infecc¸ão  por  vírus  sincicial  respiratório  como  causa  de  internac¸ão  na  populac¸ão  com
menos  de  1  ano  na  Colômbia
Resumo
Objetivo:  determinar  a  frequência,  as  complicac¸ões  e  a  sazonalidade  com  que  a  infecc¸ão  pelo
vírus sincicial  respiratório  (VSR)  do  trato  respiratório  inferior  causa  hospitalizac¸ão  em  neonatos
com  um  ano  de  idade  ou  menos,  em  seis  cidades  da  Colômbia.
Métodos:  estudo  observacional  prospectivo  multicêntrico  de  um  ano  que  incluiu  717  pacientes,
que compareceram  ao  servic¸o de  emergência  com  sintomas  respiratórios  em  seis  cidades  da
Colômbia.  As  crianc¸as  hospitalizadas  foram  testadas  para  veriﬁcar  a  existência  de  VSR  com
teste  de  imunoﬂuorescência  das  secrec¸ões  nasofaríngeas.  Foram  realizadas  análises  descritivas
e  estatísticas  da  populac¸ão.
Resultados: a  populac¸ão  estudada  incluiu  717  pacientes  com  uma  idade  média  de  3,6  meses
(DP 3,25),  na  proporc¸ão  de  4:3  do  sexo  masculino  para  o  sexo  feminino  e  uma  prevalência  de
ITRI  por  VSR  de  30%  (216  neonatos/cidade,  faixa  26-49%).  Os  fatores  de  risco  para  ITRI  por  VSR
foram  encontrados  em  8,2%  da  populac¸ão,  dos  quais  28,8%  foram  positivos  para  VSR.  Os  grupos
positivo  e  negativo  para  VSR  foram  comparados  utilizando  um  teste  t  bicaudal  com  IC  de  95%,
p  <  0,05.  Não  foram  constatadas  diferenc¸as  estatisticamente  signiﬁcativas.  Todas  as  cidades
apresentaram  trimestres  anuais  especíﬁcos  para  ocorrência  de  ITRI  por  VSR.
Conclusões: o  VSR  causou  uma  em  três  internac¸ões  de  ITRI  na  populac¸ão,  com  uma  incidência
de 30%.  Isso  conﬁrma  uma  circulac¸ão  contínua  do  VSR  na  Colômbia,  que  varia  pela  localizac¸ão
geográﬁca.
© 2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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The  Respiratory  Syncytial  Virus  (RSV)  infection  is  a global
public health  problem  and  is  the  leading  cause  of  lower  res-
piratory tract  infection  (LRTI)  in  the  pediatric  population.1,2
In  Latin  America,  respiratory  infections  remain  the  sec-
ond leading  cause  of  death  in  children  under  5  years  of
age with  RSV  as  the  causative  agent  in  70.0%  of  these
infections.3,4
RSV  infection  produces  hospitalization  in  2.0%  of  the
pediatric population  and  causes  a  more  severe  clinical
course with  up  to  20.0%  of  hospitalization  in  premature
infants (<36  weeks  of  gestational  age),  and  children  with
bronchopulmonary dysplasia,  congenital  heart  disease,  or
neuromuscular and  immune  diseases.1,5--7Studies  of  RSV
infection in  Latin  American  countries  have  shown  a  range
of RSV  presence  from  21.6%  to  60.0%  in  children  with  LRTI
and a  range  in  hospitalized  children  for  LRTI  from  41.8%  to
78.7%.3 In  Colombia,  some  studies  have  reported  an  inci-
dence of  hospitalization  for  RSV  in  LRTI  between  41.7%  and
48.0%.6,8,9
In  relation  to  seasonality,  the  incidence  of  RSV  infec-
tion varies  according  to  latitude,  altitude,  and  weather  of
each of  the  regions.10 In  countries  with  seasons,  RSV  occurs
in an  epidemic  form  in  the  winter  season.  In  tropical  and
subtropical areas,  endemic  patterns  have  been  described,
with interspersed  epidemic  periods,  although  not  clear  in
different geographic  areas.3,11
It  is  known  that  RSV  epidemics  were  recorded  in  the
months of  greatest  rainfalls  and  colder  temperatures.  How-
ever, other  reports  suggest  that  in  the  equatorial  regions,
RSV infection  is  evenly  distributed  throughout  the  year,  with
some variable  increases.9,11
i
h
oIn  Colombia,  there  are  records  of  RSV  infection  in  differ-
nt cities.9,11 However,  local  studies  about  the  seasonality
f infection  are  limited.
In Bogotá  (the  capital  of  Colombia),  an  endemic  pattern
f RSV  infection  has  been  reported  primarily,  with  a  peak
ccurrence of  bronchiolitis  in  the  ﬁrst  half  of  the  year,  corre-
ated with  the  rainy  season  (April-June).11 Ministry  of  Health
n its  epidemiologic  monitoring  report  of  Bogotá  has  con-
rmed that  most  of  the  deaths  that  occur  annually  during
he respiratory  epidemic  of  the  ﬁrst  half  of  the  year  are
ttributed to  RSV,  and  occur  especially  in  infants  under  one
ear of  age.12
In  other  cities  of  Colombia  the  seasonality  as  well  as
he reports  of  RSV  infection  and  frequent  complications
n speciﬁc  pediatric  age  groups  is  few.  Due  to  this  lack  of
nformation, the  objective  of  this  study  is  to  determine  the
easonality, frequency  and  high-risk  patient  complications  of
SV LRTI  in  children  less  or  equal  to  one  year  of  age  requiring
ospitalization in  six  selected  institutions  in  different  cities
f Colombia.
aterials and methods
he  design  was  a  prospective  multicentric  observational
tudy, including  medical  institutions  located  in  six  cities
f Colombia  (Bogotá,  Cali,  Medellín,  Barranquilla,  Bucara-
anga and  Pereira),  lasting  one  calendar  year  (April
005--April 2006).
The  selected  institutions  were  characterized  by  report-
ng between  1000-2000  pediatric  visits  monthly  and  100-200
ospitalizations for  LRTI  in  infants  of  one  year  of  age  or  less.
Given  previous  reports  of  RSV  positivity  on  around  50.0%
f patients  hospitalized  for  LRTI  in  Colombia,  we  calculated
546  Pin˜eros  JG  et  al.
Table  1  Respiratory  syncytial  virus  positivity  by  city.
City  Number  of  participants  RSV  positivity
n  =  717 % n  =  216 %
Barranquilla  47  6.6  17  36.2
Bogotá  296  41.3 77  26.0
Bucaramanga  54  7.5 16  29.6
Cali  92  12.8 26  28.3
Medellín  102  14.2  50  49.0
Pereira  126  17.6  30  23.8
RSV, respiratory syncytial virus.
Table  2  Comparison  between  positive  and  negative  respiratory  syncytial  virus  patients.
Parameters  RSV  negative  RSV  positive  two-tailed  t-test(p-value)
Hospitalization  age  3.7  months  3.5  months  NS
Sex 58.6%  57.2%  0.739
Prematurity 6.8%  6.5%  0.881
Pulmonary chronic  disease  8.4%  7.9%  0.819
Mortality 0.0%  0.8%  0.185
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bRSV, respiratory syncytial virus.
 minimum  sample  size  of  500  patients  of  one  year  or  less
ospitalized with  suspicion  of  RSV  LRTI.
The  total  number  of  patients  included  in  the  study  was
17 and  met  the  following  inclusion  criteria:  1)  to  be  one
ear of  age  or  less  2)  to  have  visited  the  emergency  depart-
ent and  been  hospitalized  for  suspicion  of  LRTI  (diagnosis
f bronchiolitis,  pneumonia,  or  bronchopneumonia).
After  the  patients  were  hospitalized,  the  presence
r absence  of  RSV  was  conﬁrmed  by  performing  a
apid immunoﬂuorescence  test  in  nasopharyngeal  secretion
Clearview RSV  antigen  detection  test).  The  reported  test
ensitivity was  95.2%,  speciﬁcity  99.3%,  PPV  95.2%  and  NPV
f 99.3%.13 The  results  of  the  test  were  veriﬁed  through  an
nzyme immunoassay  (Directigen  RSV),  performed  in  one
f the  institutions  participating  in  the  study  (Clinic  of  the
mericas, Medellín).13
Risk  factors  such  as  gestational  age  less  than  32  weeks
t birth,  and  chronic  lung  disease  were  determined.  Clin-
cal outcomes  such  as  average  hospital  stay,  admission
o the  pediatric  intensive  care  unit,  mechanical  ventila-
ion requirement,  and  mortality  were  assessed  in  high-risk
atients. RSV  positive  and  negative  groups  were  com-
ared.
All the  protocols  and  informed  consent  were  reviewed
nd approved  by  the  ethics  committee  of  each  institu-
ion.
tatistical  analysis
 descriptive  analysis  of  the  population  was  conducted.  Inci-
ence of  patients  with  conﬁrmed  RSV  LRTI  was  calculated  by
rimester and  city.  RSV  positive  and  negative  groups  were
ompared using  a  two-tailed  t  test  with  95%  CI,  p  <  0.05.
he results  were  compared  between  cities.  The  statistical
oftware SAS  9.0  was  used.
d
t
A
aesults
he  total  number  of  patients  included  in  the  study  was  717
nfants that  met  the  inclusion  criteria.
The  average  age  of  the  patients  was  3.6  months  (SD  3.25),
ith a male/female  ratio  of  4:3.  The  primary  diagnoses  of
he patients  included:  bronchiolitis  in  67.0%,  pneumonia  in
3.0%, bronchopneumonia  in  9.8%,  and  other  in  0.3%.
The  RSV  test  was  positive  in  216  patients,  which  cor-
esponds to  an  incidence  of  30.0%  in  the  general  study
opulation (Table  1).  In  the  other  cities  the  range  of  vari-
bility of  RSV  positivity  was  23.8%  to  49.0%  (Table  1).
In  relation  to  presenting  risk  factors  for  RSV  LRTI,  59
atients (8.2%)  had  risk  factors  such  as  gestational  age  less
han 32  weeks  at  birth,  or  chronic  lung  disease.  The  RSV  test
as positive  in  28.8%  of  these  patients,  which  suggests  that
n the  high-risk  patients  the  infection  proportion  is  similar
o the  general  population.
In the  RSV  positive  high-risk  patients,  the  average  hospi-
al stay  was  8.6  days  per  patient,  and  52.9%  were  admitted
o the  Pediatric  Intensive  Care  Unit  (PICU)  with  an  aver-
ge stay  of  8.3  days  per  patient.  Of  these  patients,  41.2%
equired mechanical  ventilation  for  3.8  days  on  average.
ortality was  5.8%  (Table  2).
After  comparing  the  group  of  RSV  positive  and  negative
atients, there  were  no  statistically  signiﬁcant  differences
etween the  analyzed  parameters  such  as  hospitalization
ge, sex,  prematurity,  chronic  lung  disease  and  mortality
Table 2).
Fig. 1  shows  the  incidence  of  RSV  positive  cases  detected
y trimesters  in  different  cities.  In  general  the  RSV  LRTI  inci-
ence among  cities  was  not  statistically  different.  At  most,
here is  an  epidemic  trend  of  RSV  occurrence  during  the
pril-June trimester  of  the  year  with  the  highest  percent-
ge of  RSV  positive  cases  in  the  cities  of  Bogotá  and  Medellín.
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The  other  cities  had  similar  incidences  of  RSV  positive  cases
throughout the  year.
Discussion and conclusions
This  study  conﬁrms  that  the  Respiratory  Syncytial  Virus  is
a frequent  cause  of  hospitalization  for  LRTI  in  infants  of
one year  of  age  or  less  in  Colombia,  with  an  incidence
of 30.0%,  not  only  in  the  general  population  but  also  in
high-risk patients,  which  is  comparable  with  previous  local
studies.8,9,11,12,14 In  the  city  of  Cali.14 ﬁndings  showed  that  in
a cohort  of  340  infants  followed  for  18  months,  RSV  was  the
most common  causative  agent  of  RTI  with  13.0%  RSV  posi-
tivity of  the  viral  isolated  and  known  to  occur  endemically
throughout the  year.8 In  Medellín  a  44.0%  RSV  positivity  was
reported in  the  overall  monitoring  of  pediatric  patients  with
LRTI, from  which  77.0%  of  patients  were  under  one  year  of
age.6,8 Another  study  in  Medellín  showed  a  41.7%  incidence
of RSV  in  children  of  less  than  one  year  of  age  hospitalized
for LRTI.  Infants  with  conﬁrmed  RSV  infection  had  an  aver-
age age  of  3.2  months  (SD  +/-  2.9),  with  82.2%  of  the  cases
appearing before  six  months  of  age  and  62.8%  presenting
cases before  two  months  of  age  with  an  average  RSV  posi-
tive case  hospitalization  of  6.1  days  (SD  +/-  3.4).13 Our  study
ﬁndings are  consistent  with  these  previous  local  reports,  and
also with  international  reports  of  7.8%  of  patients  with  risk
factors (prematurity  or  chronic  lung  disease).3,6 In  these  hos-
pitalized high-risk  patients  RSV  was  conﬁrmed  in  1  out  of  3
patients, and  complications  and  mortality  were  high.
Most  patients  of  one  year  of  age  or  less  were  hospitalized
for RSV  LRTI  before  six  months  of  age,  which  means  that  they
could beneﬁt  from  RSV  prophylaxis.1,6
Overall  RSV  can  occur  in  Colombia  throughout  the  year  in
an endemic  pattern  with  some  peaks  of  increased  hospital-
ization. These  periods  do  not  necessarily  coincide  between
cities, which  can  be  partly  explained  by  climatic  differences
given by  periods  of  rainfall,  relative  humidity,  height  above
sea level  and  daily  temperature  variability.
In  addition  to  the  above  results,  longitudinal  studies
are recommended  to  assess  RSV  incidence  and  prophylaxisatory  syncytial  virus  by  trimesters  by  city.
mplementation  across  the  country  to  prevent  RSV  infection,
nd to  decrease  complications  and  mortality  in  infants.
The  limitations  in  our  study  include  the  small  sample  sizes
er city  (irrespective  of  a  good  total  sample  size  of  717),
he total  duration  time  of  one  calendar  year,  since  some
imilar studies  last  longer  periods,  and  the  fact  that  RSV
rophylaxis implementation  was  not  assessed,  which  could
ave provided  information  on  the  course  of  the  disease  in
hese populations.
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